Fixed Timelines. Guaranteed GMP Quantities.
No Surprises.
GMP material in accelerated timelines to get you to the clinic
Fixed pricing and guaranteed* titers
Proven platforms that don't compromise on quality
mAbs Offer
Push your monoclonal antibody projects to the next stage.
The Antibody Service that Gets You to the Clinic Fast and Efficiently
The mAb drug substance you need for phase I, just the way you need it - fast, easy and effective.
AGCellerate™ mAbs gives you guaranteed* speed and product quantity to begin your clinical work while maintaining quality and minimizing risks. Our streamlined process gets you from DNA transfection to clinical-ready GMP drug substance in only 11 months.
Program Benefits
- 1.0 kg Phase I/II mAb Drug Substance in 11 months*
- Expedite critical medicines into the clinic
- Fixed pricing with no surprises with lower development costs to help maintain your fixed budget and burn rate.
- Access to a proprietary platform, CHEF1™, a proven commercial cell line that has produced 4 commercial products and 54 molecules at various stages of clinical development.
- A service that grows as you need, ready for the late stage and commercials stages when you are.
- A direct and seamless transfer to cGMP manufacturing.
*For specific antibodies; subject to terms and conditions.
Accelerate your MAb Journey
Complete details on AGCellerate for mAbs
Learn more about the offering and AGC's proven FDA/EMA-approved cell line development system.
View technical details
LVV Offering
The LVV titers you need in a rapid timeline.
A Lentiviral Vector Service to Ease your Path to Phase I in 9 months*
We use our proven plug-and-play method to get you LVV product you need in a timeline that beats industry averages.
AGCellerate LVV offers developers - particularly those focused on rare diseases - a quick and proven path to accelerate your therapy right to the clinic.
Program Benefits
- A minimum of 1e11 total TU LVV in one of the fastest timelines available to the industry.
- No price surprises. Our fixed pricing is straightforward and includes raw materials - allowing you to forecast the budget accordingly.
- Supported by the plug-and-play ProntoLVV™ Platform, offering streamlined, rapid development of clinical materials and pre-qualified by regulators for commercial stages.
- Proprietary AGC adherent HEK293T cells and packaging plasmids included
- Built by a team of scientists who understand operational and regulatory needs and have a track record of successful pre-clinical development and commercial manufacturing.
*For specific vector projects; this offering is subject to terms and conditions.
Accelerate your LVV journey
Complete details on AGCellerate for LVV
Learn about the offering and our commercially-approved ProntoLVV platform.
View technical details
The guarantee your project needs - no surprises
AGCellerate (ag·cell·er·ate) offers GMP material in rapid timelines that support clinical goals.